Future Directions to Establish Lipoprotein(a) as a Treatment for Atherosclerotic Cardiovascular Disease
1
Metabolic and Atherosclerosis Research Center, Cincinnati, USA
|
Publication type: Journal Article
Publication date: 2016-02-09
scimago Q1
wos Q2
SJR: 1.002
CiteScore: 9.0
Impact factor: 3.1
ISSN: 09203206, 15737241
PubMed ID:
26861250
General Medicine
Pharmacology
Cardiology and Cardiovascular Medicine
Pharmacology (medical)
Abstract
In both epidemiologic and genetic studies, increased levels of Lp(a) have been associated with increased risk for cardiovascular diseases as well as aortic stenosis. However, until recently, it has been difficult to lower levels of Lp(a). Diet and lifestyle have little effect on plasma levels of Lp(a) which are mainly genetically determined. Emerging therapeutic agents which have recently become available, or which are undergoing clinical trials, can significantly lower Lp(a) levels. Studies with these agents will hopefully be able to provide more direct information whether reductions in Lp(a) will reduce CVD events independently of reduction in LDL-cholesterol levels.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
|
|
|
Journal of Clinical Lipidology
4 publications, 16.67%
|
|
|
Lipids in Health and Disease
2 publications, 8.33%
|
|
|
Journal of the American College of Cardiology
2 publications, 8.33%
|
|
|
Pharmacological Research
2 publications, 8.33%
|
|
|
International Journal for Vitamin and Nutrition Research
1 publication, 4.17%
|
|
|
Circulation Research
1 publication, 4.17%
|
|
|
Frontiers in Cardiovascular Medicine
1 publication, 4.17%
|
|
|
Current Atherosclerosis Reports
1 publication, 4.17%
|
|
|
Current Diabetes Reports
1 publication, 4.17%
|
|
|
Clinica Chimica Acta
1 publication, 4.17%
|
|
|
European Journal of Internal Medicine
1 publication, 4.17%
|
|
|
Atherosclerosis
1 publication, 4.17%
|
|
|
Critical Reviews in Clinical Laboratory Sciences
1 publication, 4.17%
|
|
|
European Heart Journal
1 publication, 4.17%
|
|
|
Annals of Translational Medicine
1 publication, 4.17%
|
|
|
1
2
3
4
|
Publishers
|
2
4
6
8
10
12
|
|
|
Elsevier
12 publications, 50%
|
|
|
Springer Nature
4 publications, 16.67%
|
|
|
IMR Press
1 publication, 4.17%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 4.17%
|
|
|
Frontiers Media S.A.
1 publication, 4.17%
|
|
|
Taylor & Francis
1 publication, 4.17%
|
|
|
Oxford University Press
1 publication, 4.17%
|
|
|
AME Publishing Company
1 publication, 4.17%
|
|
|
Wiley
1 publication, 4.17%
|
|
|
2
4
6
8
10
12
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
24
Total citations:
24
Citations from 2024:
2
(8.34%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Stein E. A., Raal F. Future Directions to Establish Lipoprotein(a) as a Treatment for Atherosclerotic Cardiovascular Disease // Cardiovascular Drugs and Therapy. 2016. Vol. 30. No. 1. pp. 101-108.
GOST all authors (up to 50)
Copy
Stein E. A., Raal F. Future Directions to Establish Lipoprotein(a) as a Treatment for Atherosclerotic Cardiovascular Disease // Cardiovascular Drugs and Therapy. 2016. Vol. 30. No. 1. pp. 101-108.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1007/s10557-016-6654-5
UR - https://doi.org/10.1007/s10557-016-6654-5
TI - Future Directions to Establish Lipoprotein(a) as a Treatment for Atherosclerotic Cardiovascular Disease
T2 - Cardiovascular Drugs and Therapy
AU - Stein, Evan A.
AU - Raal, Frederick
PY - 2016
DA - 2016/02/09
PB - Springer Nature
SP - 101-108
IS - 1
VL - 30
PMID - 26861250
SN - 0920-3206
SN - 1573-7241
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2016_Stein,
author = {Evan A. Stein and Frederick Raal},
title = {Future Directions to Establish Lipoprotein(a) as a Treatment for Atherosclerotic Cardiovascular Disease},
journal = {Cardiovascular Drugs and Therapy},
year = {2016},
volume = {30},
publisher = {Springer Nature},
month = {feb},
url = {https://doi.org/10.1007/s10557-016-6654-5},
number = {1},
pages = {101--108},
doi = {10.1007/s10557-016-6654-5}
}
Cite this
MLA
Copy
Stein, Evan A., and Frederick Raal. “Future Directions to Establish Lipoprotein(a) as a Treatment for Atherosclerotic Cardiovascular Disease.” Cardiovascular Drugs and Therapy, vol. 30, no. 1, Feb. 2016, pp. 101-108. https://doi.org/10.1007/s10557-016-6654-5.